| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/01/1999 | WO1999032094A1 Compositions for the transdermal and dermal administration of biologically active agents |
| 07/01/1999 | WO1999032092A1 Process for manufacturing bite-dispersion tablets |
| 07/01/1999 | WO1999032091A1 Oral pharmaceutical extended release dosage form |
| 07/01/1999 | WO1999032089A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
| 07/01/1999 | WO1999032088A1 Aqueous insecticidal pour-on formulation |
| 07/01/1999 | WO1999032087A1 Water-soluble eye drop |
| 07/01/1999 | WO1999032085A2 Novel pharmaceutical compositions of uridine triphosphate |
| 07/01/1999 | WO1999032083A1 Microparticles and their therapeutic or diagnostic use |
| 07/01/1999 | WO1999032082A2 Pharmaceutical compositions |
| 07/01/1999 | WO1999032076A1 Use of hyperbranched polymers and dendrimers comprising a particular group as film-forming agent, film-forming compositions comprising same and use particularly in cosmetics and pharmaceutics |
| 07/01/1999 | WO1999032072A1 Compositions and methods for treatment of alopecia |
| 07/01/1999 | WO1999031987A1 Topical carbamazepine formulations and methods of use |
| 07/01/1999 | WO1999010014A3 Receptor-mediated gene delivery using bacteriophage vectors |
| 07/01/1999 | DE19756261A1 Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide New pyridylalkane aryl, alkene and alkincarbonsäureamide |
| 07/01/1999 | DE19756235A1 Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide New piperidinylsubstituierte pyridylalkane alkene and -alkincarbonsäureamide |
| 07/01/1999 | DE19744809C1 Porous glass ceramic based on calcium phosphate useful as a bone substitute, drug, protein or cell substrate or filter aid |
| 07/01/1999 | CA2318434A1 Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumor vascular endothelium |
| 07/01/1999 | CA2316248A1 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| 07/01/1999 | CA2316171A1 Microparticles and their therapeutic or diagnostic use |
| 07/01/1999 | CA2316018A1 Novel pharmaceutical compositions of uridine triphosphate |
| 07/01/1999 | CA2316015A1 Keratinocyte growth factor-2 formulations |
| 07/01/1999 | CA2315782A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
| 07/01/1999 | CA2315301A1 Protein binding polypeptides |
| 07/01/1999 | CA2315300A1 Insoluble compositions for controlling blood glucose |
| 07/01/1999 | CA2315201A1 Application of enzyme prodrugs as anti-infective agents |
| 07/01/1999 | CA2315088A1 Process for manufacturing bite-dispersion tablets |
| 07/01/1999 | CA2315032A1 Dna pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof |
| 07/01/1999 | CA2314868A1 Topical carbamazepine formulations and methods of use |
| 07/01/1999 | CA2313316A1 Compositions comprising cannabinoids |
| 07/01/1999 | CA2313163A1 Pharmaceutical compositions |
| 07/01/1999 | CA2312040A1 Hyperbranched polymers or dendrimers having a particular group, preparation method and compositions containing same |
| 07/01/1999 | CA2311294A1 Use of hyperbranched polymers and dendrimers comprising a particular group as film-forming agent, film-forming compositions comprising same and use particularly in cosmetics and pharmaceutics |
| 06/30/1999 | EP0925792A2 Insoluble compositions for controlling blood glucose |
| 06/30/1999 | EP0925785A1 Stabilised pharmaceutical compositions containing dopamine or dobutamine |
| 06/30/1999 | EP0925502A1 Diagnostic and therapeutic nucleotide or nucleoside photoaffinity compound modified antibodies, and use thereof |
| 06/30/1999 | EP0925358A1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use |
| 06/30/1999 | EP0925308A2 Compositions and methods for treating infections using analogues of indolicidin |
| 06/30/1999 | EP0925065A1 Water miscible erythromycin solutions |
| 06/30/1999 | EP0925061A1 Compositions comprising microparticles of water-insoluble substances and method for preparing same |
| 06/30/1999 | EP0925060A1 Fast decomposing pellets |
| 06/30/1999 | EP0924996A1 Use of bilayer forming emulsifiers in nutritional compositions comprising divalent metal salts |
| 06/30/1999 | EP0725141A4 Method of controlled genetic transformation of an animal mammary gland and a device for introducing genetic material into the mammary duct of an animal mammary gland |
| 06/30/1999 | EP0470128B1 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 06/30/1999 | CN1221398A 甘露糖醇及其制备 Mannitol and its preparation |
| 06/30/1999 | CN1221338A Use of H2-antagonists for manufacture of topical composition for treatment of colds |
| 06/30/1999 | CN1221337A Liquisolid system and method of preparing the same |
| 06/30/1999 | CN1221334A Detergent composition for skin |
| 06/30/1999 | CN1220874A Drug composition with controlled drug release rate |
| 06/29/1999 | US5917670 In a hard disk drive |
| 06/29/1999 | US5917017 Diphtheria toxin vaccines bearing a mutated R domain |
| 06/29/1999 | US5916998 For use as matrix supports for controlled drug delivery |
| 06/29/1999 | US5916883 Acylated cyclodextrin derivatives |
| 06/29/1999 | US5916882 Povidone iodine (PVP-I) alcohol gel antimicrobial pre-operative skin preparation |
| 06/29/1999 | US5916803 Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their use |
| 06/29/1999 | US5916793 Arginine deiminase derived from Mycoplasma arthritidis and polymer conjugates containing the same |
| 06/29/1999 | US5916790 Encapsulation compositions, and methods |
| 06/29/1999 | US5916755 Relates to genes which encode novel proteins related to a family of receptor proteins typified by two related membrane spanning tyrosine kinases: the epidermal growth factor receptor, which is encoded by the erbb gene, and the receptor |
| 06/29/1999 | US5916598 First and second phases are combined to form an emulsion in which the first phase is discontinuous and the second phase is continuous. the phases are immersed in a quench liquid. |
| 06/29/1999 | US5916597 Composition and method using solid-phase particles for sustained in vivo release of a biologically active agent |
| 06/29/1999 | US5916596 Water insoluble drugs and drug delivery |
| 06/29/1999 | US5916590 Soft gelatin pharmaceutical dosage form |
| 06/29/1999 | US5916589 Pharmaceutical compositions comprising cyclosporins |
| 06/29/1999 | US5916587 Transdermal delivery matrix for piroxicam |
| 06/29/1999 | US5916583 Precipitation of one or more active compounds in situ |
| 06/29/1999 | US5916582 Aqueous formulations of peptides |
| 06/29/1999 | US5916581 Iodine antimicrobial compositions containing nonionic surfactants and halogen anions |
| 06/29/1999 | US5916571 Cleaving a streptococcus pneumoniae serotype 8-polysaccharide into oligosaccharides to preserve immunogenic epitopes, separating above oligosaccharides based on size, selecting oligosaccharide which conatins antigen, mixing with antigen |
| 06/29/1999 | US5916566 Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds |
| 06/29/1999 | US5916550 C2-7 aliphatic amino acid is added to an aqueous suspension of loteprednol etabonate for topical ophthalmic use, the suspension does not undergo ph depression even on prolonged storage, with the result that no irritable response is |
| 06/29/1999 | US5916547 Water or alcohol soluble |
| 06/29/1999 | US5916545 Topical antifungal agent consists of tioconazole, water, alcohol and water soluble gel forming agent selected from a resin derived from cellulose, glucose or sucrose and a plasticizer; useful for treating onychomycosis |
| 06/29/1999 | US5916539 Superparamagnetic particles, process for producing the same and their use |
| 06/29/1999 | US5916371 Crystalline powdery saccsharide, its preparation and uses |
| 06/29/1999 | CA2156063C Sucrose ester c-20 to c-28 alcohol formulations |
| 06/29/1999 | CA2153542C Application of hollow deformable particles in a cosmetic and/or dermatologic composition containing fatty compounds |
| 06/29/1999 | CA2132936C Stabilized pharmaceutical compositions and stabilizing solvent |
| 06/29/1999 | CA2048200C Polylactide in a purified state, method for the production therof, and pharmaceutical compositions |
| 06/29/1999 | CA2016584C Anthracycline conjugates having a novel linker and methods for their production |
| 06/24/1999 | WO1999031510A1 β(1-3)-GLUCAN DIAGNOSTIC ASSAYS |
| 06/24/1999 | WO1999031262A2 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | WO1999031119A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes |
| 06/24/1999 | WO1999031064A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 06/24/1999 | WO1999031060A2 Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants |
| 06/24/1999 | WO1999030745A2 Dota-biotin derivatives |
| 06/24/1999 | WO1999030741A2 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases |
| 06/24/1999 | WO1999030740A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| 06/24/1999 | WO1999030727A1 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 06/24/1999 | WO1999030714A1 Sustained-release theophylline preparation and process for producing the same |
| 06/24/1999 | WO1999030702A1 Percutaneously absorbable levodopa-containing preparation |
| 06/24/1999 | WO1999030694A2 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 06/24/1999 | WO1999030693A2 A double capsule for the administration of active principles in multiple therapies |
| 06/24/1999 | WO1999030688A1 Methods of lyophilizing solutions |
| 06/24/1999 | WO1999030570A1 Animal feed pelleting process and animal feed pellets produced therefrom |
| 06/24/1999 | WO1999019359A9 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 06/24/1999 | WO1999015509A3 Cyclohexyl and heterocyclyl nucleoside derivatives, method for producing these derivatives, and the use of the derivatives and their oligomers or conjugates in pairing and/or testing systems |
| 06/24/1999 | WO1999007728A3 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 06/24/1999 | DE19849228A1 Use of compositions containing vitamin E and chitosan |
| 06/24/1999 | DE19845246A1 Vitamin E compositions |
| 06/24/1999 | CA2315256A1 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | CA2315224A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |